Loustalot, Fleetwood

Trends in Cardiovascular Health Metrics and Associations With All-Cause and CVD Mortality Among US Adults

Yang, Q., Cogswell, M. E., Flanders, W. D., Hong, Y., Zhang, Z., Loustalot, F., Gillespie, C., Merritt, R., & Hu, F. B. (2012) · JAMA

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 802

Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study

Joffres, M., Falaschetti, E., Gillespie, C., Robitaille, C., Loustalot, F., Poulter, N., McAlister, F. A., Johansen, H., Baclic, O., & Campbell, N. (2013) · BMJ Open

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 464

Trend and Prevalence Estimates Based on the 2008 Physical Activity Guidelines for Americans

Carlson, S. A., Fulton, J. E., Schoenborn, C. A., & Loustalot, F. (2010) · American Journal of Preventive Medicine

Physical Activity and HealthObesity, Physical Activity, Diet

Cited by 415

Heterogeneity in Obesity Prevalence Among Asian American Adults

Shah, N. S., Luncheon, C., Kandula, N. R., Khan, S. S., Pan, L., Gillespie, C., Loustalot, F., & Fang, J. (2022) · Annals of Internal Medicine

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 51

Nonmedical Marijuana Use and Cardiovascular Events: A Systematic Review

Yang, P. K., Odom, E. C., Patel, R., Loustalot, F., & Coleman King, S. (2022) · Public Health Reports®

Cannabis and Cannabinoid ResearchAcute Myocardial Infarction Research

Cited by 28

The Impact of Cardiovascular Risk-Factor Profiles on Blood Pressure Control Rates in Adults From Canada and the United States

McAlister, F. A., Robitaille, C., Gillespie, C., Yuan, K., Rao, D. P., Grover, S., Dai, S., Johansen, H., Joffres, M., Loustalot, F., et al. (2013) · Canadian Journal of Cardiology

Blood Pressure and Hypertension StudiesHealth Promotion and Cardiovascular Prevention

Cited by 25

State-Level Variation in Glucagon-Like Peptide-1 Receptor Agonists Fills and Spending by Obesity Prevalence, 2023

Khan, T., Tsipas, S., Loustalot, F., Zasadzinski, L., Myftari, K., Goodman, A. B., & Wozniak, G. D. (2025) · Journal of the American Heart Association

Diabetes Treatment and ManagementHealthcare Policy and Management

Cited by 4